Abstract : Mature lymphoid B-cell proliferations with hairy cells represent heterogeneous entities where specific diagnosis is difficult but important since it impacts therapeutic management. The clinical cases of variant hairy cell leukemia reported herein illustrate the persistence of a clear interest in the use of splenectomy as a therapeutic alternative. Furthermore, ibrutinib appears to be a promising treatment in patients with relapsed/refractory disease.
https://hal-normandie-univ.archives-ouvertes.fr/hal-02194328
Contributeur : Université Normandie
<>
Soumis le : jeudi 25 juillet 2019 - 14:02:48
Dernière modification le : lundi 29 juillet 2019 - 15:10:33
